NCT06290856View on ClinicalTrials.gov

Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2025

Conditions
Metastatic Colorectal CancerPancreas AdenocarcinomaCholangiocarcinoma
Interventions
DIAGNOSTIC_TEST

Multiplex PCR-test for circulating tumor DNA

All recruited patients will be tested for

Trial Locations (1)

Unknown

RECRUITING

Oslo university Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER